REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Cambridge Diagnostics (Polska) Sp. z o.o. (Poland)

Main Activities: Wholesale Trade Agents and Brokers
Full name: Cambridge Diagnostics (Polska) Sp. z o.o. Profile Updated: May 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Cambridge Diagnostics Polska is a medical institution based in Warsaw, Poland, specializing in modern laboratory diagnosis of intestinal intolerance IgG, neurotransmitter and stress hormones, and Nutrigenetics. The company has been helping patients recover from chronic illness for over fifteen years and collaborates with scientists and clinics in various fields.

Headquarters
Ul. Gornoslaska 4A
Warsaw; Mazowieckie; Postal Code: 00-444

Contact Details: Purchase the Cambridge Diagnostics (Polska) Sp. z o.o. report to view the information.

Website: http://www.cambridge-diagnostics.pl

Basic Information
Total Employees:
Purchase the Cambridge Diagnostics (Polska) Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Cambridge Diagnostics (Polska) Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Cambridge Diagnostics (Polska) Sp. z o.o. report to view the information.
Incorporation Date:
March 18, 2014
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Ownership Details
Purchase this report to view the information.
51%
Purchase this report to view the information.
24.5%
Purchase this report to view the information.
24.5%
Company Performance
Financial values in the chart are available after Cambridge Diagnostics (Polska) Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-8.61%▼
Total operating revenue
-9.15%▼
Operating profit (EBIT)
47.97%▲
EBITDA
38.77%▲
Net Profit (Loss) for the Period
9.33%▲
Total assets
9.15%▲
Total equity
11.67%▲
Operating Profit Margin (ROS)
6.44%▲
Net Profit Margin
2.43%▲
Return on Equity (ROE)
-0.23%▼
Quick Ratio
1.45%▲
Cash Ratio
1.54%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo